DE60318395D1 - R-(-)-1-i2-(7-CHLOROBENZO-iB -THIOPHEN-3-YL-METHOXY)-2-(2,4-DICHLORPHENYL)ETHYL -1H-IMIDAZOL - Google Patents
R-(-)-1-i2-(7-CHLOROBENZO-iB -THIOPHEN-3-YL-METHOXY)-2-(2,4-DICHLORPHENYL)ETHYL -1H-IMIDAZOLInfo
- Publication number
- DE60318395D1 DE60318395D1 DE60318395T DE60318395T DE60318395D1 DE 60318395 D1 DE60318395 D1 DE 60318395D1 DE 60318395 T DE60318395 T DE 60318395T DE 60318395 T DE60318395 T DE 60318395T DE 60318395 D1 DE60318395 D1 DE 60318395D1
- Authority
- DE
- Germany
- Prior art keywords
- thiophen
- imidazole
- methoxy
- ethyl
- dichlorphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200200328A ES2203316B1 (es) | 2002-02-11 | 2002-02-11 | R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol. |
| ES200200328 | 2002-02-11 | ||
| PCT/EP2003/001089 WO2003068770A1 (en) | 2002-02-11 | 2003-02-04 | R- (-) -1- [2- (7-CHLOROBENZO [b] THIOPHEN-3 -YL- METHOXY) -2- (2,4-DICHLOROPHENYL) -ETHYL] -1H-IMIDAZOLE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60318395D1 true DE60318395D1 (de) | 2008-02-14 |
| DE60318395T2 DE60318395T2 (de) | 2009-01-02 |
Family
ID=27675919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60318395T Expired - Lifetime DE60318395T2 (de) | 2002-02-11 | 2003-02-04 | R-(-)-1-[2-(7-chlorobenzo-[b]-thiophen-3-yl-methoxy)-2-(2,4-dichlorphenyl)ethyl]-1h-imidazol |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7323433B2 (de) |
| EP (1) | EP1474422B1 (de) |
| JP (1) | JP5095070B2 (de) |
| KR (1) | KR100701457B1 (de) |
| CN (1) | CN1315824C (de) |
| AT (1) | ATE382618T1 (de) |
| AU (1) | AU2003205733B8 (de) |
| BR (1) | BR0307754A (de) |
| CA (1) | CA2474627C (de) |
| CO (1) | CO5601026A2 (de) |
| DE (1) | DE60318395T2 (de) |
| DK (1) | DK1474422T3 (de) |
| ES (1) | ES2203316B1 (de) |
| HK (1) | HK1070883A1 (de) |
| IL (1) | IL163452A (de) |
| MX (1) | MXPA04007581A (de) |
| NO (1) | NO327937B1 (de) |
| NZ (1) | NZ534464A (de) |
| PL (1) | PL211168B1 (de) |
| PT (1) | PT1474422E (de) |
| RU (1) | RU2276152C1 (de) |
| TN (1) | TNSN04140A1 (de) |
| UA (1) | UA78010C2 (de) |
| WO (1) | WO2003068770A1 (de) |
| ZA (1) | ZA200405941B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2249991B1 (es) * | 2004-09-13 | 2007-03-01 | Ferrer Internacional, S.A. | Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos. |
| ES2249992B1 (es) * | 2004-09-13 | 2007-03-01 | Ferrer Internacional, S.A. | Un procedimiento para fabricar compuestos enantiomericos del imidazol. |
| EP1698336A1 (de) * | 2005-03-01 | 2006-09-06 | Ferrer Internacional, S.A. | Antimykotischezusammensetzungen enthaltend Sertaconazol und entweder Hydrokortison oder einen antibakteriellen Wikrstoff |
| CA2742711A1 (en) * | 2008-12-09 | 2010-06-17 | Ferrer Internacional, S.A. | Polymorph ii of an antifungal compound |
| EP2436374A1 (de) * | 2010-09-30 | 2012-04-04 | Ferrer Internacional, S.A. | Ovulus zur vaginalen Verabreichung von Arasertaconazol |
| EP2551351A1 (de) | 2011-07-29 | 2013-01-30 | Interquim, S.A. | Verfahren zur Herstellung von optisch aktivem (R)-(-)-1-(2,4-dichlor-phenyl)-2-imidazol-1-yl-ethanol |
| CN102440947B (zh) * | 2011-11-15 | 2012-12-26 | 海南海神同洲制药有限公司 | 硝酸舍他康唑乳膏剂 |
| KR101717968B1 (ko) | 2016-07-18 | 2017-03-20 | 씨앤아이 주식회사 | 스마트폰 결합 모듈 |
| CN113480517B (zh) * | 2021-07-30 | 2022-09-09 | 海南海神同洲制药有限公司 | 3-溴甲基-7-氯苯并[b]噻吩的合成方法 |
| CN113735843B (zh) * | 2021-09-07 | 2023-05-26 | 海南海神同洲制药有限公司 | 一种低熔点硝酸舍他康唑的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5135943A (en) * | 1984-02-02 | 1992-08-04 | Ferrer Internacional S.A. | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same |
| CA1250586A (en) * | 1984-02-02 | 1989-02-28 | Manuel Raga | 1h-imidazole derivatives and process for their production |
| US5087620A (en) * | 1990-05-17 | 1992-02-11 | Bristol-Myers Squibb Co. | Controlled dermal penetration enhancement using imidazoles |
| DE69503364T2 (de) * | 1995-01-04 | 1999-04-15 | Ferrer Int | Verfahren zur herstellung von polymorphe b und c von 1-(2,4-dichloro-beta-((7-chloro-benzo(b)thien-3-yl)methoxy)phenethyl) imidazol-mononitrat |
-
2002
- 2002-02-11 ES ES200200328A patent/ES2203316B1/es not_active Expired - Fee Related
-
2003
- 2003-02-04 CN CNB038036592A patent/CN1315824C/zh not_active Expired - Fee Related
- 2003-02-04 NZ NZ534464A patent/NZ534464A/en not_active IP Right Cessation
- 2003-02-04 BR BR0307754-3A patent/BR0307754A/pt not_active IP Right Cessation
- 2003-02-04 AT AT03702597T patent/ATE382618T1/de active
- 2003-02-04 WO PCT/EP2003/001089 patent/WO2003068770A1/en active IP Right Grant
- 2003-02-04 PT PT03702597T patent/PT1474422E/pt unknown
- 2003-02-04 MX MXPA04007581A patent/MXPA04007581A/es active IP Right Grant
- 2003-02-04 EP EP03702597A patent/EP1474422B1/de not_active Expired - Lifetime
- 2003-02-04 CA CA002474627A patent/CA2474627C/en not_active Expired - Fee Related
- 2003-02-04 DK DK03702597T patent/DK1474422T3/da active
- 2003-02-04 AU AU2003205733A patent/AU2003205733B8/en not_active Ceased
- 2003-02-04 RU RU2004127573/04A patent/RU2276152C1/ru not_active IP Right Cessation
- 2003-02-04 PL PL370251A patent/PL211168B1/pl unknown
- 2003-02-04 DE DE60318395T patent/DE60318395T2/de not_active Expired - Lifetime
- 2003-02-04 KR KR1020047012352A patent/KR100701457B1/ko not_active IP Right Cessation
- 2003-02-04 JP JP2003567897A patent/JP5095070B2/ja not_active Expired - Fee Related
- 2003-04-02 UA UA20040806675A patent/UA78010C2/uk unknown
-
2004
- 2004-07-26 ZA ZA200405941A patent/ZA200405941B/en unknown
- 2004-07-29 TN TNP2004000140A patent/TNSN04140A1/en unknown
- 2004-08-05 US US10/911,572 patent/US7323433B2/en not_active Expired - Fee Related
- 2004-08-06 CO CO04076775A patent/CO5601026A2/es not_active Application Discontinuation
- 2004-08-10 IL IL163452A patent/IL163452A/en not_active IP Right Cessation
- 2004-08-13 NO NO20043377A patent/NO327937B1/no not_active IP Right Cessation
-
2005
- 2005-01-18 HK HK05100468A patent/HK1070883A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1070883A1 (en) | R-(-)-1-2-(7-chlorobenzo-b-thiophen-3-yl-methoxy)-2(2,4-dichlorophenyl)ethyl-1h-imidazole | |
| CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
| AP2000001942A0 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections. | |
| MY125356A (en) | Moxifloxacin/sodium chloride formulation | |
| BR0317564A (pt) | Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos | |
| WO2004029031A3 (en) | Therapeutic piperazine compounds | |
| WO2004016086A3 (en) | 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents | |
| MXPA05000765A (es) | Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos. | |
| MY136449A (en) | N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide for the treatment of cancer | |
| WO2000016757A8 (de) | Verwendung von phosphororganischen verbindungen zur herstellung von arzneimitteln zur therapeutischen und prophylaktischen behandlung von infektionen oder als fungizid, bakterizid oder herbizid bei pflanzen | |
| ATE260559T1 (de) | Sordarinderivate | |
| ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| WO2002055022A3 (en) | Active metabolite of antifungal compound | |
| BG104259A (en) | Derivatives of 4-cyano-4-deformylsordaricin | |
| WO2003007878A3 (en) | Antifungal agents of sordarin derivatives | |
| ATE241979T1 (de) | 4-cyano-4-deformylsordarinderivate | |
| BRPI0414319A (pt) | agentes antibacterianos de quinolona | |
| AP2001002164A0 (en) | Use of phosphonoformic acid derivatives for treating infections. | |
| CR7413A (es) | R-(-)-1-[2-(7-Chlorobenzo[b]thiophen-3-yl-methozy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole | |
| MXPA05013760A (es) | Composicion y procedimiento de tratamiento del platanero y del bananero. | |
| ECSP003603A (es) | Formulacion de sal comun y moxifloxacina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |